An analytical laboratory, nothing else.
CRAFA was founded in 2017 in a converted Cambridge warehouse by a small group of synthetic chemists and analytical scientists. After a decade between academic biochemistry and contract manufacturing, we had watched the gap between research-grade and pharma-grade peptide standards widen, and replication studies stall. The problem wasn't intent — it was infrastructure.
We test what gets sold. Peptides, SARMs, anabolic steroids, SERMs, sexual-health compounds, harm-reduction samples — the materials of the modern research-compound economy. We do not manufacture, distribute, or hold inventory. We are the laboratory layer between vendors and the people who depend on accurate labels.
Independent testing matters because trust scales poorly. A vendor's own certificate of analysis tells you what they want you to know. An independent COA — one with raw data retained by a third party, traceable to a verifiable code — tells you what the compound actually is.
"Transparency, precision, harm reduction. The rest is paperwork."
Reports are signed by named analysts. Raw chromatograms are retained for seven years and available to the originating client on request.
Independence is structural.
We do not sell, manufacture, or distribute
Methods are validated.
ISO/IEC 17025 · UKAS scope #4421
Privacy is technical.
Encrypted reports · anonymous intake available
Transparency is published.
Public Results · blind-testing programme
The analytical stack.
Two analytical bays, redundant on every critical instrument. Calibration cycle reviewed weekly; method-detection-limits re-verified quarterly.
Visit the laboratory.
Institutional partners and prospective collaborators are welcome to tour our Cambridge facility by appointment.
Request a visit →